Cargando…
Intravenous Delivery of RNA Encoding Anti-PD-1 Human Monoclonal Antibody for Treating Intestinal Cancer
Recently, antibody-based therapeutic agents are becoming most leading biologics for treating many diseases, especially for cancer. However, large-scale application of antibody drugs is still hampered by high cost and complex technical process. Endogenous expression of proteins or antibodies can be a...
Autores principales: | Wu, Lipei, Wang, Weiwei, Tian, Jiale, Qi, Chunrun, Cai, Zhengxin, Yan, Wenhui, Xuan, Shihai, Shang, Anquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771528/ https://www.ncbi.nlm.nih.gov/pubmed/35069904 http://dx.doi.org/10.7150/jca.63991 |
Ejemplares similares
-
Engineered mRNA-expressed bispecific antibody prevent intestinal cancer via lipid nanoparticle delivery
por: Wu, Lipei, et al.
Publicado: (2021) -
Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer
por: Wu, Lipei, et al.
Publicado: (2022) -
Cervical Cancer Cells-Derived Extracellular Vesicles Containing microRNA-146a-5p Affect Actin Dynamics to Promote Cervical Cancer Metastasis by Activating the Hippo-YAP Signaling Pathway via WWC2
por: Wang, Weiwei, et al.
Publicado: (2022) -
Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer via FOSB-Mediated Downregulation of MicroRNA-22 through BATF3/PD-L1 Pathway
por: Tian, Jiale, et al.
Publicado: (2022) -
Neuropeptide Y in the amygdala contributes to neuropathic pain-like behaviors in rats via the neuropeptide Y receptor type 2/mitogen-activated protein kinase axis
por: Yan, Wenhui, et al.
Publicado: (2022)